Keyphrases
Autosomal Dominant Alzheimer's Disease
62%
Alzheimer's Disease
48%
Dominantly Inherited Alzheimer Network
24%
Mutation Carriers
23%
Dominantly Inherited Alzheimer's Disease
23%
Symptom Onset
19%
Cerebrospinal Fluid
17%
Autosomal Dominant
14%
Non-carriers
14%
Sporadic Alzheimer's Disease
13%
Pittsburgh Compound B
13%
Cognitive Decline
13%
Dementia
12%
Clinical Trials
11%
Disease Progression
9%
Neurodegeneration
9%
Mild Cognitive Impairment
9%
Alzheimer's Disease Pathology
8%
White Matter Hyperintensities
7%
Late-onset Alzheimer's Disease
7%
Presenilin
7%
Amyloid Deposition
7%
Clinical Dementia Rating
7%
Prevention Trials
7%
Cognitively Normal
7%
Age of Onset
6%
Disease-causing mutations
6%
Amyloid PET
6%
Alzheimer's Disease Biomarkers
6%
Amyloid Imaging
6%
Biomarker Changes
6%
Amyloid Positron Emission Tomography
6%
Atrophy
6%
Hippocampal Volume
6%
Total tau
6%
Positron Emission Tomography
6%
Amyloid Burden
5%
Rate of Change
5%
Imaging Biomarkers
5%
Phosphorylated tau
5%
Longitudinal Change
5%
Gantenerumab
5%
Medicine and Dentistry
Alzheimer's Disease
69%
Autosomal Dominant Inheritance
36%
Amyloid Protein
35%
Biological Marker
21%
Cerebrospinal Fluid
16%
Tau
15%
Positron Emission Tomography
10%
Pittsburgh Compound B
9%
Diseases
8%
Polyethylene Terephthalate
7%
Magnetic Resonance Imaging
6%
Clinical Trial
5%
Observational Study
5%
Gantenerumab
5%
Neuroscience
Alzheimer's Disease
100%
Amyloid Protein
46%
Positron Emission Tomography
15%
Positron Emission Tomography
14%
Clinical Dementia Rating
11%
Neurodegeneration
10%
Magnetic Resonance Imaging
9%
Mild Cognitive Impairment
9%
Functional Connectivity
6%
Cognitive Disorders
5%
Blood Plasma
5%
Beta Amyloid
5%
Amyloidosis
5%